Migraine Minute News Update 9.29.23: Botulinum Toxin for Pediatric Migraine
Release Date: 09/29/2023
No Link Between Migraine and Risk of Parkinson’s Disease
Migraine Minute News Update
Contrary to previous research, a study published in Neurology finds among women, there is no link between migraine and the risk of developing Parkinson’s disease. Molly O’Brien explains in this Migraine Minute News Update. Want to know more about Migraine and Parkinson’s disease? Check out this article in AMD’s Comorbidities library:
info_outline
New Treatment Targets PACAP for Migraine Prevention
Migraine Minute News Update
A small study published in the New England Journal of Medicine finds a single IV infusion of a Monoclonal Antibody targeting PACAP reduced monthly migraine days better than placebo. In this Migraine Minute News Update @Molly O’Brien explains. Read More:
info_outline
NINDS Funds Research on the Link Between Headache Disorders & the Circadian Clock
Migraine Minute News Update
The National Institute of Neurological Disorders and Stroke awards a $2.4 million grant to researchers at the University of Texas Health to examine the link between the circadian clock and severe headache disorders. Molly O’Brien has details in this Migraine Minute News Update. Read more: bit.ly/3BsNwfT
info_outline
Can CGRP blockers impact blood pressure in people over 60?
Migraine Minute News Update
A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O’Brien explains the findings. Read More: bit.ly/3zpcYSB
info_outline
Are CGRP mAbs Cost Effective?
Migraine Minute News Update
A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too. Read more: Image courtesy: DOI 10.1186/s10194-024-01727-0
info_outline
Atogepant vs. Rimegepant. New study looks at indirect comparison
Migraine Minute News Update
A new study looks at the efficacy and safety of two gepant medications. Molly O'Brien will share the study findings in this Migraine Minute News update. Read the study: Image courtesy: Sage Journals. Cephalalgia doi:
info_outline
Is there a link between photophobia and poor sleep quality?
Migraine Minute News Update
Light sensitivity and poor sleep quality in people with migraine, could the two be related? In a study published in the Journal of Headache and Pain, researchers looked at the impact photophobia may have on sleep quality in people with migraine. Molly O’Brien breaks it down in this Migraine Minute News Update. Learn more:
info_outline
Can a caffeine habit impact episodic migraine?
Migraine Minute News Update
Caffeine habit? A new study looks at the link between episodic migraine and regular caffeine intake. Molly O’Brien will fill you in, in this latest Migraine Minute News Update. Learn more about the study at bit.ly/4bzLyXu
info_outline
FDA Clears a New TENS Device for Migraine Prevention
Migraine Minute News Update
The US FDA clears another wearable drug-free migraine treatment device. In this Migraine Minute News Update, Molly O’Brien will tell you all about a new TENS device available for people with episodic migraine. Read more:
info_outline
Do CGRP Monoclonal Antibodies wear off at the end of the month?
Migraine Minute News Update
Many people with chronic migraine worry that their monthly preventive medication won’t work as well at the end of the month as it did at the beginning. New research shows that two injectable CGRP monoclonal antibodies do not wear off at the end of the month. Molly O’Brien has the details in this #MigraineMinute News Update. Read more:
info_outlineNew research shows that botulinum toxin treatments for migraine in adolescents may be more effective than past studies state. Molly O’Brien will fill you in on the latest in this week’s Migraine Minute News Update. For more information: https://www.sciencedirect.com/science/article/abs/pii/S0887899423002138